SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as traders debate the company's valuation, upcoming earnings expectations, and the impact of recent bond and share conversions on its balance sheet. While some participants express frustration over price stagnation and call for strategic announcements, others maintain a bullish outlook based on the firm's cash position and eBay investment.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla shares are trending as traders debate the company's invite-only Cybercab launch event, with sentiment divided between enthusiasm for the potential autonomous future and skepticism regarding the lack of a public livestream and potential regulatory hurdles. Many participants are expressing caution, citing a history of 'sell-the-news' price action surrounding company events.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending following strong second-quarter results, where the company exceeded revenue and earnings expectations. While some traders expressed concern over weaker third-quarter guidance and SpaceX's constrained launch capacity, the broader sentiment remains extremely bullish on the company's backlog and its leadership in geospatial intelligence.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares plummeted after the company reported disappointing quarterly results and slashed its full-year outlook, citing weakened North American demand and inconsistent performance from new product launches. The community is sharply divided, with some investors debating the potential for a turnaround under new leadership, while others view the stock as a 'falling knife' and express frustration over the brand's perceived loss of quality and market relevance.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath trended heavily around its quarterly earnings release, which featured a headline revenue beat and raised full-year guidance that fueled intense debate over the company's growth trajectory and agentic AI strategy. While bullish traders highlighted strong fundamentals and the potential for a short squeeze, skeptics expressed concern over margin compression and limited growth acceleration, leading to high volatility and significant disagreement on whether the results justify a long-term re-rating.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending following its fiscal fourth-quarter earnings report, where a double beat and raised guidance for the upcoming fiscal year were met with mixed reactions. While many traders highlight strong demand for AI-driven security and a solid report, some express concerns over decelerating growth and high-value customer acquisition trends, leading to post-earnings price volatility.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is experiencing downward price pressure following the announcement of Anil Chakravarthy as the next CEO, with community discussion split between those viewing the internal hire as a stabilizing move for continuity and others interpreting it as a failure to attract external leadership. Traders remain cautious, weighing the leadership transition against lingering investor concerns over generative AI competition and broader software sector volatility.

Victoria's Secret & Co. operates as a lingerie, clothing and beauty retailer. It offers bras, panties, lingerie, sleepwear, apparel, sport and swim apparel, and beauty products. The company was founded in 1963 and is headquartered in Reynoldsburg, OH.

Victoria`s Secret & Co

Victoria's Secret shares plummeted as investors reacted to second-quarter sales that fell short of Wall Street's elevated expectations, despite the company reporting an earnings beat and raising its full-year revenue outlook. While some traders expressed disappointment over the revenue miss, many retail investors on the community forum viewed the sell-off as a buying opportunity, citing the company's progress with its ongoing turnaround strategy.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

CIENA Corp. is experiencing a significant pullback following its latest quarterly report, with the stock price dropping double digits despite beating earnings expectations. The primary community conversation centers on disappointment over the market's negative reaction to the strong results, with many traders debating whether this is a temporary profit-taking event or a sign of a broader valuation reset after the stock's massive rally over the past year.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following a series of bullish analyst initiations that highlight its growth potential in the space economy, alongside an insider stock purchase by a company director. Despite these positive developments, retail sentiment remains polarized, with many traders expressing frustration over recent launch delays and share price volatility, leading to ongoing debate about the company's execution capabilities versus its long-term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cramer's lightning round: Nuvation Bio 'is a pure spec'

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...

Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 91.9% in Nuvation Bio (NUVB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nuvation Bio to Participate in Upcoming Investor Conferences

Nuvation Bio to Participate in Upcoming Investor Conferences Nuvation Bio to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, Sept. 2, 2026 NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest...

Nuvation Bio (NUVB) Upgraded to Buy: Here's Why

Nuvation Bio (NUVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma PR Newswire NEW YORK, Aug. 20, 2026 Designation offers pathway to expedite regulatory review...

Wall Street Analysts Predict a 105.71% Upside in Nuvation Bio (NUVB): Here's  What You Should Know

The mean of analysts' price targets for Nuvation Bio (NUVB) points to a 105.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Nuvation Bio (NUVB) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +16.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update PR Newswire NEW YORK, Aug. 6, 2026 Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in...

Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses

Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI (taletrectinib) in Advanced ROS1-Positive...

• Reported GAAP EPS of -$0.18 down -5.88% YoY
• Reported revenue of $31.69M up 555.64% YoY

Nuvation Bio faces significant risks from its reliance on the successful commercialization of IBTROZI, a history of substantial operating losses, and a dependence on third-party manufacturing and distribution networks.

Nuvation Bio strengthened its financial position through a $250 million convertible note offering and expanded its global commercial footprint for taletrectinib via a new license agreement with Eisai.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug

Equity

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$6.77
Prev Close	$6.93
Open	$7.03
Dividend Yield	0.00%
50-Day Moving Average	$6.33
Beta	1.60
Avg. Volume	5.52M
PE Ratio	-15.56

52-Week High	$9.75
52-Week Low	$2.99
Market Capitalization	$2.44B
EPS (Annual)	-$0.5991
Price to Book	9.33
Revenue Per Employee	$211,080.54

Feed

News

Sentiment

Earnings

Fundamentals

Info

NUVB Fundamentals